Holderness Investments Company’s Labcorp LH Stock Holding History

Holderness Investments Company’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.11M	Hold	4,164	–	–	0.22%	94
2025 Q4	$1.04M	Hold	4,164	–	–	0.21%	90
2025 Q3	$1.2M	Hold	4,164	–	–	0.24%	80
2025 Q2	$1.09M	Sell	4,164 -688	-14%	-$168K	0.24%	87
2025 Q1	$1.13M	Sell	4,852 -105	-2%	-$25.5K	0.26%	83
2024 Q4	$1.14M	Buy	4,957 +203	+4%	+$46.6K	0.25%	86
2024 Q3	$1.06M	Sell	4,754 -178	-4%	-$39.1K	0.23%	97
2024 Q2	$1M	Buy	4,932 +275	+6%	+$55.9K	0.24%	96
2024 Q1	$1.02M	Sell	4,657 -5	-0.1%	-$1.1K	0.25%	93
2023 Q4	$1.06M	Buy	4,662 +38	+0.8%	+$7.98K	0.29%	84
2023 Q3	$930K	Sell	4,624 -758	-14%	-$160K	0.36%	70
2023 Q2	$1.12M	Hold	5,382	–	–	0.41%	61
2023 Q1	$1.06M	Buy	5,382 +11	+0.2%	+$2.26K	0.42%	60
2022 Q4	$1.09M	Hold	5,371	–	–	0.47%	60
2022 Q3	$945K	Sell	5,371 -145	-3%	-$29.7K	0.43%	64
2022 Q2	$1.11M	Sell	5,516 -18	-0.3%	-$3.84K	0.46%	56
2022 Q1	$1.25M	Hold	5,534	–	–	0.42%	61
2021 Q4	$1.49M	Sell	5,534 -40	-0.7%	-$9.9K	0.44%	58
2021 Q3	$1.35M	Buy	5,574 +145	+3%	+$36.5K	0.45%	60
2021 Q2	$1.29M	Hold	5,429	–	–	0.43%	60
2021 Q1	$1.19M	Buy	5,429 +356	+7%	+$71.4K	0.43%	62
2020 Q4	$887K	Sell	5,073 -143	-3%	-$24.7K	0.34%	81
2020 Q3	$844K	Hold	5,216	–	–	0.35%	75
2020 Q2	$744K	Hold	5,216	–	–	0.33%	76
2020 Q1	$566K	Buy	5,216 +483	+10%	+$69.6K	0.32%	83
2019 Q4	$688K	Hold	4,733	–	–	0.29%	95
2019 Q3	$683K	Sell	4,733 -886	-16%	-$129K	0.32%	92
2019 Q2	$835K	Buy	5,619 +88	+2%	+$12.3K	0.38%	75
2019 Q1	$727K	Buy	5,531 +30	+0.5%	+$3.7K	0.35%	80
2018 Q4	$597K	Sell	5,501 -170	-3%	-$22.8K	0.33%	83
2018 Q3	$846K	Buy	5,671 +87	+2%	+$13.2K	0.38%	77
2018 Q2	$861K	Hold	5,584	–	–	0.42%	75
2018 Q1	$776K	Buy	5,584 +294	+6%	+$43.2K	0.38%	80
2017 Q4	$725K	Sell	5,290 -98	-2%	-$13K	0.36%	86
2017 Q3	$699K	Hold	5,388	–	–	0.36%	91
2017 Q2	$714K	Buy	5,388 +174	+3%	+$21.3K	0.38%	89
2017 Q1	$643K	Buy	5,214 +1,053	+25%	+$125K	0.33%	98
2016 Q4	$459K	Buy	4,161 +87	+2%	+$9.66K	0.41%	77
2016 Q3	$481K	Hold	4,074	–	–	0.48%	71
2016 Q2	$456K	Hold	4,074	–	–	0.46%	74
2016 Q1	$410K	Hold	4,074	–	–	0.39%	82
2015 Q4	$433K	Sell	4,074 -116	-3%	-$12K	0.43%	73
2015 Q3	$390K	Hold	4,190	–	–	0.41%	81
2015 Q2	$436K	Buy	4,190 +1,746	+71%	+$182K	0.45%	78
2015 Q1	$265K	Sell	2,444 -1,164	-32%	-$120K	0.27%	100
2014 Q4	$334K	Buy	+3,608	New	+$319K	0.34%	87

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Holderness Investments Company's LH Position: Q1 2026 in Review

Holderness Investments Company held its Labcorp (LH) position steady in Q1 2026 at 4,164 shares worth $1.11M. The position accounts for 0.22% of the portfolio, ranked #94.

Holderness Investments Company first reported a position in LH in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.49M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Holderness Investments Company held 4,164 shares of Labcorp worth $1.11M as of Q1 2026.
Holderness Investments Company left its Labcorp share count unchanged in Q1 2026.
Labcorp made up 0.22% of Holderness Investments Company's portfolio in Q1 2026, its #94 holding.
Holderness Investments Company first reported a position in Labcorp in Q4 2014 and has held it in 46 quarters since.
Holderness Investments Company's Labcorp position peaked at $1.49M in Q4 2021.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Holderness Investments Company's 13F filing for Q1 2026, filed 12 May 2026.